202 related articles for article (PubMed ID: 34389699)
1. Analysis of genetic differences between psychiatric disorders: exploring pathways and cell types/tissues involved and ability to differentiate the disorders by polygenic scores.
Rao S; Yin L; Xiang Y; So HC
Transl Psychiatry; 2021 Aug; 11(1):426. PubMed ID: 34389699
[TBL] [Abstract][Full Text] [Related]
2. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
[TBL] [Abstract][Full Text] [Related]
3. Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits.
So HC; Sham PC
Bioinformatics; 2017 Mar; 33(6):886-892. PubMed ID: 28065900
[TBL] [Abstract][Full Text] [Related]
4. Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes.
Su MH; Shih YH; Lin YF; Chen PC; Chen CY; Hsiao PC; Pan YJ; Liu YL; Tsai SJ; Kuo PH; Wu CS; Huang YT; Wang SH
Diabetologia; 2022 May; 65(5):800-810. PubMed ID: 35195735
[TBL] [Abstract][Full Text] [Related]
5. Polygenic associations of neurodevelopmental genes in suicide attempt.
Sokolowski M; Wasserman J; Wasserman D
Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
[TBL] [Abstract][Full Text] [Related]
6. Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study.
Mullins N; Perroud N; Uher R; Butler AW; Cohen-Woods S; Rivera M; Malki K; Euesden J; Power RA; Tansey KE; Jones L; Jones I; Craddock N; Owen MJ; Korszun A; Gill M; Mors O; Preisig M; Maier W; Rietschel M; Rice JP; Müller-Myhsok B; Binder EB; Lucae S; Ising M; Craig IW; Farmer AE; McGuffin P; Breen G; Lewis CM
Am J Med Genet B Neuropsychiatr Genet; 2014 Jul; 165B(5):428-37. PubMed ID: 24964207
[TBL] [Abstract][Full Text] [Related]
7. A cross-disorder PRS-pheWAS of 5 major psychiatric disorders in UK Biobank.
Leppert B; Millard LAC; Riglin L; Davey Smith G; Thapar A; Tilling K; Walton E; Stergiakouli E
PLoS Genet; 2020 May; 16(5):e1008185. PubMed ID: 32392212
[TBL] [Abstract][Full Text] [Related]
8. Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene-environment correlation.
Machlitt-Northen S; Keers R; Munroe PB; Howard DM; Trubetskoy V; Pluess M
J Child Psychol Psychiatry; 2022 Oct; 63(10):1140-1152. PubMed ID: 35781881
[TBL] [Abstract][Full Text] [Related]
9. Association of Genetic Risk Factors for Psychiatric Disorders and Traits of These Disorders in a Swedish Population Twin Sample.
Taylor MJ; Martin J; Lu Y; Brikell I; Lundström S; Larsson H; Lichtenstein P
JAMA Psychiatry; 2019 Mar; 76(3):280-289. PubMed ID: 30566181
[TBL] [Abstract][Full Text] [Related]
10. Polygenic Risk Scores Derived From Varying Definitions of Depression and Risk of Depression.
Mitchell BL; Thorp JG; Wu Y; Campos AI; Nyholt DR; Gordon SD; Whiteman DC; Olsen CM; Hickie IB; Martin NG; Medland SE; Wray NR; Byrne EM
JAMA Psychiatry; 2021 Oct; 78(10):1152-1160. PubMed ID: 34379077
[TBL] [Abstract][Full Text] [Related]
11. Discriminating bipolar depression from major depressive disorder with polygenic risk scores.
Liebers DT; Pirooznia M; Ganna A; ; Goes FS
Psychol Med; 2021 Jul; 51(9):1451-1458. PubMed ID: 32063240
[TBL] [Abstract][Full Text] [Related]
12. Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data.
Gibson J; Russ TC; Adams MJ; Clarke TK; Howard DM; Hall LS; Fernandez-Pujals AM; Wigmore EM; Hayward C; Davies G; Murray AD; Smith BH; Porteous DJ; Deary IJ; McIntosh AM
Transl Psychiatry; 2017 Apr; 7(4):e1094. PubMed ID: 28418403
[TBL] [Abstract][Full Text] [Related]
13. Studying individual risk factors for self-harm in the UK Biobank: A polygenic scoring and Mendelian randomisation study.
Lim KX; Rijsdijk F; Hagenaars SP; Socrates A; Choi SW; Coleman JRI; Glanville KP; Lewis CM; Pingault JB
PLoS Med; 2020 Jun; 17(6):e1003137. PubMed ID: 32479557
[TBL] [Abstract][Full Text] [Related]
14. Genetic predispositions to psychiatric disorders and the risk of COVID-19.
Chen W; Zeng Y; Suo C; Yang H; Chen Y; Hou C; Hu Y; Ying Z; Sun Y; Qu Y; Lu D; Fang F; Valdimarsdóttir UA; Song H
BMC Med; 2022 Aug; 20(1):314. PubMed ID: 35999565
[TBL] [Abstract][Full Text] [Related]
15. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
16. EXPLORATORY ANALYSIS OF POLYGENIC RISK SCORES FOR PSYCHIATRIC DISORDERS: APPLIED TO DUAL DIAGNOSIS.
Martínez-Magaña JJ; Gonzalez-Castro TB; Genís-Mendoza AD; Tovilla-Zárate CA; Juárez-Rojop IE; Saucedo-Uribe E; Rodríguez-Mayoral O; Lanzagorta N; Escamilla M; Macías-Kauffer L; Nicolini H
Rev Invest Clin; 2019; 71(5):321-329. PubMed ID: 31599879
[TBL] [Abstract][Full Text] [Related]
17. Shared polygenic risk for ADHD, executive dysfunction and other psychiatric disorders.
Chang S; Yang L; Wang Y; Faraone SV
Transl Psychiatry; 2020 Jun; 10(1):182. PubMed ID: 32518222
[TBL] [Abstract][Full Text] [Related]
18. Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings.
Maxwell JM; Coleman JRI; Breen G; Vassos E
JAMA Psychiatry; 2021 Dec; 78(12):1355-1364. PubMed ID: 34705035
[TBL] [Abstract][Full Text] [Related]
19. Depression with atypical neurovegetative symptoms shares genetic predisposition with immuno-metabolic traits and alcohol consumption.
Badini I; Coleman JRI; Hagenaars SP; Hotopf M; Breen G; Lewis CM; Fabbri C
Psychol Med; 2022 Mar; 52(4):726-736. PubMed ID: 32624019
[TBL] [Abstract][Full Text] [Related]
20. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
